New insider activity at Orasure Technologies ( (OSUR) ) has taken place on March 4, 2025.
In a notable move, President & CEO Carrie Manner Eglinton has acquired 28,670 shares of Orasure Technologies, amounting to a significant investment of $99,771. Additionally, Director Nancy J. Gagliano has also shown confidence in the company by purchasing 12,750 shares, valued at $39,270.
Recent Updates on OSUR stock
OraSure Technologies recently reported its Q4 2024 earnings, highlighting a 10% growth in core revenue despite a 51% decline in total net revenues, primarily due to a sharp decrease in COVID-19 related revenues. The company emphasized its strategic transformation efforts, including the acquisition of Sherlock Biosciences to enhance its molecular diagnostics capabilities. Additionally, OraSure secured FDA approval to expand the age range for its OraQuick HIV self-test, potentially broadening its market. However, uncertainties remain due to potential reductions in NIH funding and US foreign aid programs, impacting its international diagnostics revenue. Despite these challenges, OraSure remains optimistic about its growth prospects, supported by a strong balance sheet and ongoing strategic initiatives.
More about Orasure Technologies
YTD Price Performance: -1.69%
Average Trading Volume: 964,594
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $259.6M